⌘K

Home/Filings/4/0001127602-23-005162

4//SEC Filing

SCHEIBLER LUKAS 4

Accession 0001127602-23-005162

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:44 PM ET

Size

4.4 KB

Accession

0001127602-23-005162

Insider Transaction Report

Form 4

Period: 2023-02-10

Apellis Pharmaceuticals, Inc.APLS

SCHEIBLER LUKAS

See Remarks

Transactions

Tax Payment
Common Stock
2023-02-10$51.21/sh−678$34,720→ 60,472 total

Footnotes (1)

[F1]This represents shares withheld for tax on a restricted stock unit release.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001651281

Filing Metadata

Form type: 4
Filed: Feb 13, 7:00 PM ET
Accepted: Feb 14, 4:44 PM ET
Size: 4.4 KB

View on SEC.gov